#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Antithrombin III deficiency Macular telangiectasia Peritoneal mesothelioma malignant Amyotrophic lateral sclerosis Rett syndrome Trigeminal neuralgia Fusarium infection Hyperoxaluria Heavy menstrual bleeding Lymphatic malformation Medullary thyroid cancer Colitis ulcerative Hepato-lenticular degeneration B-cell lymphoma recurrent Soft tissue necrosis More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage III – Diagnostics Congenital generalised lipodystrophy – Diagnostics Kearns-Sayre syndrome Wolfram syndrome – Trials in Disease Cholangitis sclerosing – Trials in Disease Kearns-Sayre syndrome – Treatment Acquired haemophilia – Trials in Disease Mucous membrane pemphigoid – Trials in Disease Alternating hemiplegia of childhood Brain stem glioma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Abc-35B-116 Tertomotide Heterodimeric Interleukin-15 Amoxicillin Trihydrate Ebastine Abemaciclib Bnt314 Quinine Dihydrochloride Oteracil Izokibep Dalteparin Sodium Tetrahydrouridine Clemastine Fumarate Adct-402 Fludeoxyglucose (18F) Sodium Thiosulfate Iodixanol ACETYLCARNITINE HYDROCHLORIDE Adrc001 Foscarnet Sodium Hexahydrate More therapies…

    Learn about Your Condition

    Osteoporosis Ankylosing spondylitis Skin wrinkling Malignant lymphoid neoplasm Lupus nephritis Testicular leiomyosarcoma Hepatitis D Escherichia infection Bile duct adenocarcinoma Cervix carcinoma stage IV Intellectual disability Stress urinary incontinence Phenylketonuria Haemorrhagic stroke Oxygen saturation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Gemeinschaftspraxis Drs. Josef und Wilma Großkopf

Gemeinschaftspraxis Drs. Josef und Wilma Großkopf

Ahornstr. 2a, Wallerfing, 94574, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Comparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk

    Recruiting

    3 1 1
    Investigated Drugs:
    • Bempedoic Acid
    • Obicetrapib
    Czechia Germany Italy The Netherlands Poland Slovakia +1

  • Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

    Recruiting

    3 1
    Investigated Drugs:
    • ZILEBESIRAN
    Austria Belgium Bulgaria Czechia Denmark France +11

  • Study of lavender oil (Silexan) in patients with mild to moderate major depressive disorder comparing its effectiveness to placebo

    Recruiting

    3 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Lavender Oil
    Austria Germany

  • Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

    Recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    Bulgaria Czechia Denmark France Germany Greece +7

  • Study on the Effectiveness and Safety of Ivermectin Cream Compared to a Drug Combination for Patients with Papulopustular Rosacea

    Recruiting

    3 1 1
    Investigated Diseases:
    • Papulopustular rosacea
    Investigated Drugs:
    • Ivermectin
    Germany

  • Study on the Effectiveness and Safety of Clindamycin and Tretinoin Gel for Patients with Papulopustular Acne

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acne
    Investigated Drugs:
    • Clindamycin
    • Tretinoin
    Germany

  • Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Budesonide
    • Formoterol Fumarate Dihydrate
    • Glycopyrronium Bromide
    Austria Bulgaria Czechia Denmark Finland France +10

  • Study of benzydamine hydrochloride and dichlorobenzyl alcohol lozenges for treating acute pharyngitis symptoms

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • 2,4 DICHLOROBENZYL ALCOHOL
    • BENZYDAMINE HYDROCHLORIDE
    Germany

  • Study on the Immune Response and Safety of RSVPreF3 Vaccine in Adults 18-49 at Risk for Respiratory Syncytial Virus Compared to Adults 60 and Older

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Respiratory syncytial virus bronchiolitis
    • Respiratory syncytial virus infection
    Investigated Drugs:
    • Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
    Germany

  • Study on Plozasiran and ARO-APOC3 for Adults with Severe Hypertriglyceridemia

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypertriglyceridaemia
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Bulgaria Czechia France Germany Hungary Latvia +4
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!